Edition:
India

Revance Therapeutics Inc (RVNC.OQ)

RVNC.OQ on NASDAQ Stock Exchange Global Market

33.95USD
19 Jan 2018
Change (% chg)

$0.20 (+0.59%)
Prev Close
$33.75
Open
$33.65
Day's High
$34.05
Day's Low
$33.35
Volume
71,839
Avg. Vol
104,375
52-wk High
$37.45
52-wk Low
$18.00

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.08 -1.013
Jun '17 0.08 -0.903
Mar '17 0.08 -0.943
FY 2016 Dec '16 0.08 -0.950
Sep '16 0.08 -0.638
Jun '16 0.08 -0.876
Mar '16 0.08 -0.701
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 3 0.09 0.10 0.08 0.10
Quarter Ending Jun-18 3 0.09 0.10 0.08 0.10
Year Ending Dec-18 9 0.21 0.60 0.00 0.28
Earnings (per share)
Quarter Ending Mar-18 3 -0.86 -0.71 -0.98 -0.78
Quarter Ending Jun-18 3 -0.86 -0.74 -0.97 -0.72
Year Ending Dec-18 8 -3.57 -2.93 -4.24 -2.99
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % 0.00 -21.37 -11.64
EPS (TTM) % -5.19 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Revance Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 145
Total Shares Held: 31,081,378
3 Mo. Net Change: -195,609
# New Positions: 3
# Closed Positions: 4
# Increased Positions: 10
# Reduced Positions: 10
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.